Roche Holding AG
F:RHO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Roche Holding AG
F:RHO
|
CH |
|
Scor SE
PAR:SCR
|
FR |
|
Terns Pharmaceuticals Inc
NASDAQ:TERN
|
US |
|
Chitose Internasional Tbk PT
IDX:CINT
|
ID |
Wall St Price Targets
RHO Price Targets Summary
Roche Holding AG
According to Wall Street analysts, the average 1-year price target for RHO is 396.76 EUR with a low forecast of 252.32 EUR and a high forecast of 488.13 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RHO's stock price target?
Price Target
396.76
EUR
According to Wall Street analysts, the average 1-year price target for RHO is 396.76 EUR with a low forecast of 252.32 EUR and a high forecast of 488.13 EUR.
What is the Revenue forecast for Roche Holding AG?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Roche Holding AG?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Roche Holding AG?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 14%.
